47 related articles for article (PubMed ID: 38649391)
1. Artificial intelligence in clinical care amidst COVID-19 pandemic: A systematic review.
Adamidi ES; Mitsis K; Nikita KS
Comput Struct Biotechnol J; 2021; 19():2833-2850. PubMed ID: 34025952
[TBL] [Abstract][Full Text] [Related]
2. Predictive modeling of co-infection in lupus nephritis using multiple machine learning algorithms.
Zhang J; Chen B; Liu J; Chai P; Liu H; Chen Y; Liu H; Yin G; Zhang S; Wang C; Xie Q
Sci Rep; 2024 Apr; 14(1):9242. PubMed ID: 38649391
[TBL] [Abstract][Full Text] [Related]
3. Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis.
Wang DC; Xu WD; Wang SN; Wang X; Leng W; Fu L; Liu XY; Qin Z; Huang AF
Inflamm Res; 2023 Jun; 72(6):1315-1324. PubMed ID: 37300586
[TBL] [Abstract][Full Text] [Related]
4. Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis.
Wang L; Yang Z; Yu H; Lin W; Wu R; Yang H; Yang K
Front Immunol; 2022; 13():839197. PubMed ID: 36532018
[TBL] [Abstract][Full Text] [Related]
5. Machine learning models predicts risk of proliferative lupus nephritis.
Yang P; Liu Z; Lu F; Sha Y; Li P; Zheng Q; Wang K; Zhou X; Zeng X; Wu Y
Front Immunol; 2024; 15():1413569. PubMed ID: 38919623
[TBL] [Abstract][Full Text] [Related]
6. Changes of memory B- and T-cell subsets in lupus nephritis patients.
Kosalka J; Jakiela B; Musial J
Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis.
Liu P; Li P; Peng Z; Xiang Y; Xia C; Wu J; Yang B; He Z
Lupus; 2020 Aug; 29(9):1031-1039. PubMed ID: 32501169
[TBL] [Abstract][Full Text] [Related]
8. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Choi MY; Chen I; Clarke AE; Fritzler MJ; Buhler KA; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Sontag D; Costenbader KH
Ann Rheum Dis; 2023 Jul; 82(7):927-936. PubMed ID: 37085289
[TBL] [Abstract][Full Text] [Related]
9. Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection.
Zhang J; Zhang S; Qiao J; Qiu M; Li X
Lupus; 2023 Jan; 32(1):119-128. PubMed ID: 36433710
[TBL] [Abstract][Full Text] [Related]
10. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
Steiger S; Ehreiser L; Anders J; Anders HJ
Front Immunol; 2022; 13():999704. PubMed ID: 36211360
[TBL] [Abstract][Full Text] [Related]
11. Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection.
Zhang JQ; Zhang SX; Wang J; Qiao J; Qiu MT; Wu XY; Chen JW; Gao C; Li XF
Curr Med Res Opin; 2022 Jun; 38(6):1037-1044. PubMed ID: 35414310
[TBL] [Abstract][Full Text] [Related]
12. Prediction models of treatment response in lupus nephritis.
Ayoub I; Wolf BJ; Geng L; Song H; Khatiwada A; Tsao BP; Oates JC; Rovin BH
Kidney Int; 2022 Feb; 101(2):379-389. PubMed ID: 34871620
[TBL] [Abstract][Full Text] [Related]
13. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink HJL; Sjöström CD; Jongs N; Chertow GM; Kosiborod M; Hou FF; McMurray JJV; Rossing P; Correa-Rotter R; Kurlyandskaya R; Stefansson BV; Toto RD; Langkilde AM; Wheeler DC;
Eur Heart J; 2021 Mar; 42(13):1216-1227. PubMed ID: 33792669
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
